Year: 2022

Judge Denies Calif. 340B Health Centers’ Motion to Halt State Medicaid Drug Payment Change

January 11, 2022 Ron Shinkman Views

California health centers say they will continue to fight against the transfer of state Medicaid managed care drug coverage to Medicaid fee for service, despite being denied a temporary restraining order against the change.

A federal judge in Sacramento, Calif., late yesterday declined to stop California Medicaid’s transfer of managed care drug coverage to Medicaid fee for service that took effect on Jan. 1. Health centers enrolled in the 340B drug pricing program pledged

…

340B PROVIDER LEADER SPOTLIGHT

Marcus Cox, Chief Pharmacy Officer, Klamath Health Partnership, Inc

January 11, 2022 Diane Slafsky Views

Q: Where did you go to college/graduate school?

I graduated Pharmacy school from Oregon State University in 1999. I first graduated with a BS in Chemistry from Southern Oregon

…

A Personal Look at Some of the Nation’s Top 340B Lawyers

January 11, 2022 Sponsored Content Views

Powers Team, Tackling the Big Issues in 340B

Bill von Oehsen, JD

Bill played a key role in helping to enact the 340B program in 1992, as well as to expand the law in 2010 under the Affordable Care Act to include additional safety net hospitals as covered entities and to establish numerous program integrity requirements.
Bill helped to establish 340B Health, an advocacy organization of more than 1,400 public and private nonprofit hospitals participating in the 340B program. He also helped organize the 340B Coalition, an organization of a dozen national associations

…

Appeals Court Signals it Might Send Lilly’s 340B Lawsuit Back to Lower Court

January 6, 2022 Tom Mirga Editor at Large Views

A federal circuit court has suspended Lilly’s 340B contract pharmacy lawsuit on technical grounds and might send it back to a lower court.

A federal circuit court on Tuesday halted drug manufacturer Lilly and the federal government’s appeals of a district judge’s late October ruling in Lilly’s 340B contract pharmacy lawsuit, on technical grounds. It’s the second time the case has run into

…

Judge in AstraZeneca’s 340B Case, on Verge of Big Promotion, Gives Parties Just Two Days for a Status Report

January 6, 2022 Tom Mirga Editor at Large Views

The judge in AstraZeneca’s 340B contract pharmacy lawsuit, who could be elevated soon to a federal appeals court, indicated this week that his decision in the case is still in progress.

The judge in AstraZeneca’s 340B contract pharmacy lawsuit yesterday ordered both sides to file a joint status report by no later than Friday—a sign, lawyers say, that his decision in the case is still in progress.

U.S. District Judge Leonard

…

Carole Johnson Takes Charge of HRSA and the 340B Program

January 6, 2022 Tom Mirga Editor at Large Views

Carole Johnson's tenure as HRSA administrator officially began this week Tuesday.

The U.S. Health Resources and Services Administration (HRSA), the agency that runs the 340B drug pricing program, has a permanent leader again for the first time in almost a year.

Carole Johnson started in her position as HRSA administrator on

…

California Asks Judge to Reject 340B Community Health Centers’ Request to Stop Medicaid Drug Payment Change

January 6, 2022 Ron Shinkman Views

California's state health department asked a judge yesterday to reject 340B community health centers' request to halt a major state Medicaid drug reimbursement change that began on Jan. 1.

Federally qualified health clinics in California have no right to sue to stop a major state Medicaid drug reimbursement change that began on Jan. 1., the state Department of Health Care Services (DHCS) argued in a legal brief filed Wednesday.

…

340B INDUSTRY LEADER SPOTLIGHT

Larry Crowder, Vice President, 340B Solutions, Cervey

January 6, 2022 Diane Slafsky Views

Q: Where did you grow up?

Houston, TX

Q: Where did you go to college?

Texas A&M University (College Station, TX)

Q: What are your favorites?

…

Drug Makers Want to Halt 340B Dispute Resolution Proceedings, Citing Lawsuits and Forthcoming Rule

January 4, 2022 Tom Mirga Editor at Large Views

AstraZeneca and Sanofi have asked 340B administrative dispute resolution panels to pause covered entities’ ADR proceedings against them.

Drug manufacturers AstraZeneca and Sanofi have asked 340B administrative dispute resolution panels to pause covered entities’ ADR proceedings against them until all 340B-related federal court litigation is finished and until after the government finalizes its forthcoming new 340B ADR regulation.

…

Feds Back and Kalderos Resists Pausing Company’s 340B Lawsuit

January 4, 2022 Tom Mirga Editor at Large Views

Kalderos says in a lawsuit that the federal government's 340B contract pharmacy policy is keeping it from effectively marketing its 340B Pay service to let drug companies provide 340B pricing as a post-purchase rebate rather than as a price discount.

The federal government told a judge in late December its appeal of her joint ruling in Novartis and United Therapeutics’ (UT) 340B contract pharmacy lawsuits justifies her pausing drug industry vendor Kalderos’ 340B contract pharmacy suit.

Kalderos told the judge

…